Why short stature is beneficial in duchenne muscular dystrophy-Reference-Cited by-同舟云学术

Why short stature is beneficial in duchenne muscular dystrophy

Published:2013-07-27 Issue:3 Volume:48 Page:336-342
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Bodor Marko¹²,Mcdonald Craig M.¹

Affiliation:

1. Department of Physical Medicine and Rehabilitation; University of California Davis School of Medicine; Sacramento California USA

2. Department of Neurological Surgery; University of California San Francisco School of Medicine; San Francisco California USA

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mus.23793/fullpdf

Reference53 articles.

1. Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up;Merlini;Muscle Nerve,2012

2. Corticosteroids and duchenne muscular dystrophy: Does earlier treatment really matter?;McDonald;Muscle Nerve,2012

3. Relation between height and clinical course in Duchenne muscular dystrophy;Zatz;Am J Med Genet,1988

4. The CINRG Duchenne Natural History Study: Glucocorticoid treatment preserves clinically-meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly-used clinical trial outcome measures;Henricson;Muscle Nerve

5. Short stature prolonged ambulation in boys with Duchenne muscular dystrophy;Mah;Can J Neurol Sci,2012

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corticosteroids for the treatment of Duchenne muscular dystrophy: a safety review;Expert Opinion on Drug Safety;2024-08-27

2. Disease-associated comorbidities, medication records and anthropometric measures in adults with Duchenne muscular dystrophy;Neuromuscular Disorders;2024-08

3. Longitudinal assessment of skeletal muscle functional mechanics in the DE50-MD dog model of Duchenne muscular dystrophy;Disease Models & Mechanisms;2023-12-01

4. Dystrophinopathies;Current Clinical Neurology;2023

5. Natural History and Real‐World Data in Rare Diseases: Applications, Limitations, and Future Perspectives;The Journal of Clinical Pharmacology;2022-12